Skip to main content

Table 1 Characteristic of Eyes Undergoing Intravitreal Bevacizumab Injection

From: Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells

Parameter

 

Age (years, mean ± SD*)

57.81 ± 14.11

Sex (M/F)

18/24

Diabetes mellitus

13 (31%)

Diagnosis (eyes)

 BRVO

11 (26.2%)

 AMD

10 (23.8%)

 PDR

7 (16.7%)

 CRVO

6 (14.3%)

 CSC

5 (11.9%)

 DME

3 (7.1%)

Surgical history (eyes)

 Cataract surgery

5 (11.9%)

  1. M male, F female, SD standard deviation, BRVO branch retinal vein occlusion, AMD age related macular degeneration, PDR proliferative diabetic retinopathy, CRVO central retinal vein occlusion, CSC central serous chorioretinopathy, DME diabetic macular edema